Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pleomorphic variant of invasive lobular carcinoma of the breast.

Weidner N, Semple JP.

Hum Pathol. 1992 Oct;23(10):1167-71.

PMID:
1398644
2.

Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.

Eusebi V, Magalhaes F, Azzopardi JG.

Hum Pathol. 1992 Jun;23(6):655-62.

PMID:
1592388
3.

Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution.

Orvieto E, Maiorano E, Bottiglieri L, Maisonneuve P, Rotmensz N, Galimberti V, Luini A, Brenelli F, Gatti G, Viale G.

Cancer. 2008 Oct 1;113(7):1511-20. doi: 10.1002/cncr.23811.

4.

Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.

Jacobs M, Fan F, Tawfik O.

Ann Diagn Pathol. 2012 Jun;16(3):185-9. doi: 10.1016/j.anndiagpath.2011.10.001. Epub 2011 Dec 24. Review.

PMID:
22197540
5.
6.

[Subtyping and prognostic assessment of invasive lobular breast carcinoma].

Sinn HP, Kellerhoff NM, Kellerhoff R, Bastert G, Otto HF.

Pathologe. 1997 Jan;18(1):37-44. German.

PMID:
9157403
7.

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Arpino G, Bardou VJ, Clark GM, Elledge RM.

Breast Cancer Res. 2004;6(3):R149-56. Epub 2004 Feb 17.

8.

Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?

Jayasinghe UW, Bilous AM, Boyages J.

Breast J. 2007 Sep-Oct;13(5):479-85.

PMID:
17760669
9.

Is pleomorphic lobular carcinoma really a distinct clinical entity?

Buchanan CL, Flynn LW, Murray MP, Darvishian F, Cranor ML, Fey JV, King TA, Tan LK, Sclafani LM.

J Surg Oncol. 2008 Oct 1;98(5):314-7. doi: 10.1002/jso.21121.

PMID:
18668643
10.

Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.

Bentz JS, Yassa N, Clayton F.

Mod Pathol. 1998 Sep;11(9):814-22.

PMID:
9758360
11.

Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors.

DiCostanzo D, Rosen PP, Gareen I, Franklin S, Lesser M.

Am J Surg Pathol. 1990 Jan;14(1):12-23.

PMID:
2153007
12.
13.

Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.

Chhieng DC, Tabbara SO, Marley EF, Talley LI, Frost AR.

Breast J. 2003 May-Jun;9(3):200-7.

PMID:
12752628
14.

Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.

Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ.

Breast. 2004 Oct;13(5):389-96.

PMID:
15454194
15.

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO.

Eur J Cancer. 2008 Jan;44(1):73-83. Epub 2007 Nov 26.

PMID:
18035533
16.

Cytologic appearances in invasive lobular carcinoma of the breast. A study of 21 cases.

Jayaram G, Swain M, Chew MT, Yip CH.

Acta Cytol. 2000 Mar-Apr;44(2):169-74.

PMID:
10740602
17.

Wide metastatic spreading in infiltrating lobular carcinoma of the breast.

Ferlicot S, Vincent-Salomon A, Médioni J, Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP, Sastre-Garau X.

Eur J Cancer. 2004 Feb;40(3):336-41.

PMID:
14746850
18.

Is invasive lobular carcinoma different from invasive ductal carcinoma?

Mersin H, Yildirim E, Gülben K, Berberoğlu U.

Eur J Surg Oncol. 2003 May;29(4):390-5.

PMID:
12711296
19.

Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.

Warneke J, Berger R, Johnson C, Stea D, Villar H.

Am J Surg. 1996 Nov;172(5):496-500.

PMID:
8942552
20.

Supplemental Content

Support Center